Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

BACKGROUND: Cancer cachexia syndrome (CCS) is an adverse prognostic factor in cancer patients undergoing chemotherapy or surgical procedures. We performed a prospective study to investigate the effect of CCS on treatment outcomes in patients with non-oncogene driven metastatic non-small cell lung ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Rounis, Konstantinos, Makrakis, Dimitrios, Tsigkas, Alexandros-Pantelis, Georgiou, Alexandra, Galanakis, Nikolaos, Papadaki, Chara, Monastirioti, Alexia, Vamvakas, Lambros, Kalbakis, Konstantinos, Vardakis, Nikolaos, Kontogianni, Meropi, Gioulbasanis, Ioannis, Mavroudis, Dimitrios, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435387/
https://www.ncbi.nlm.nih.gov/pubmed/34584855
http://dx.doi.org/10.21037/tlcr-21-460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435387/
https://www.ncbi.nlm.nih.gov/pubmed/34584855
http://dx.doi.org/10.21037/tlcr-21-460

Ejemplares similares